232 related articles for article (PubMed ID: 32692727)
21. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Lepore M; de Lalla C; Gundimeda SR; Gsellinger H; Consonni M; Garavaglia C; Sansano S; Piccolo F; Scelfo A; Häussinger D; Montagna D; Locatelli F; Bonini C; Bondanza A; Forcina A; Li Z; Ni G; Ciceri F; Jenö P; Xia C; Mori L; Dellabona P; Casorati G; De Libero G
J Exp Med; 2014 Jun; 211(7):1363-77. PubMed ID: 24935257
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells.
Petrov I; Suntsova M; Mutorova O; Sorokin M; Garazha A; Ilnitskaya E; Spirin P; Larin S; Kovalchuk O; Prassolov V; Zhavoronkov A; Roumiantsev A; Buzdin A
Aging (Albany NY); 2016 Nov; 8(11):2936-2947. PubMed ID: 27870639
[TBL] [Abstract][Full Text] [Related]
23. Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.
Brück O; Blom S; Dufva O; Turkki R; Chheda H; Ribeiro A; Kovanen P; Aittokallio T; Koskenvesa P; Kallioniemi O; Porkka K; Pellinen T; Mustjoki S
Leukemia; 2018 Jul; 32(7):1643-1656. PubMed ID: 29925907
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract][Full Text] [Related]
25. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
27. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
Klujber V; Koós R; Schuler D; Bocsi J
Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
[TBL] [Abstract][Full Text] [Related]
28. Immune Dysfunction After Completion of Childhood Leukemia Therapy.
Perkins JL; Harris A; Pozos TC
J Pediatr Hematol Oncol; 2017 Jan; 39(1):1-5. PubMed ID: 27820131
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia of NK-cell lineage: responses to IL-2.
Pirruccello SJ; Bicak MS; Gordon BG; Gajl-Peczalska K; Gnarra DJ; Coccia PF
Leuk Res; 1989; 13(9):735-43. PubMed ID: 2796381
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.
Tang L; Wu J; Li CG; Jiang HW; Xu M; Du M; Yin Z; Mei H; Hu Y
Clin Cancer Res; 2020 Apr; 26(7):1763-1772. PubMed ID: 31911547
[TBL] [Abstract][Full Text] [Related]
31. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
32. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
33. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
35. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
36. In vivo cell cycle characteristics of pediatric leukemia patients.
Masterson M; Lampkin B; Yousuf N; Sheikh Y; Raza A
Exp Hematol; 1992 Nov; 20(10):1184-7. PubMed ID: 1426098
[TBL] [Abstract][Full Text] [Related]
37. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
38. CD4
Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
[TBL] [Abstract][Full Text] [Related]
40. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
